Subscribe
shutterstock_284823155_constantin_stanciu
Constantin Stanciu / Shutterstock.com
11 June 2020AmericasSarah Morgan

US states sue 26 drugmakers over alleged price fixing

A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.


Editor's picks

Smart ringleader: Could Ōura’s market dominance be under threat?
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

Editor's picks

Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025
Europe
Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
18 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025

More on this story

Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

More on this story

Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

More features

GSK escalates mRNA COVID-19 vaccine dispute
Smart ringleader: Could Ōura’s market dominance be under threat?
The flaw that landed Sanofi a win in the rare disease space
Roche resolves cancer test dispute with Stanford affiliated startup
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
UK firm expands in Germany with more litigation hires
Sandoz blocked by UK court from seeking Xarelto profits
An update on patenting in Ukraine, Russia and Eurasia